Clinical Trials Directory

Trials / Terminated

TerminatedNCT04286906

Multidimensional Assessment of Dyspnea in Asthma

Status
Terminated
Phase
Study type
Observational
Enrollment
133 (actual)
Sponsor
University Hospital, Lille · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

Breathlessness is a symptom of asthma that occurs in relation with lower airway obstruction. However, this sensation is not specific of asthma and may be the expression of other disorders. In particular, it can testify to anxiety or hyperventilation, two disorders frequently associated with asthma. The systematic interpretation of dyspnea as a manifestation of asthma in asthmatic patients may lead to an inappropriate increase in asthma controllers. Identifying the cause of dyspnea in asthmatic patients (airway obstruction, anxiety or hyperventilation) is therefore crucial for the clinician. This could be facilitated by a multidimensional assessment of dyspnea, evaluating the kind of sensation felt by the patient (for example chest tightness, air hunger etc.) and emotions associated to respiratory sensations (for example anxiety, fear etc.). The objectives of this project are to assess: (1) the sensory and affective dimensions of dyspnea in asthma and, (2) their connection to asthma control, anxiety and depression.

Conditions

Interventions

TypeNameDescription
OTHERQuestionnaireMultiDimensional Profile (MDP), Anxiety-Depression Hospital Scale (HADs), Nijmegen

Timeline

Start date
2020-05-18
Primary completion
2022-08-11
Completion
2022-08-11
First posted
2020-02-27
Last updated
2023-01-26

Locations

5 sites across 1 country: France

Source: ClinicalTrials.gov record NCT04286906. Inclusion in this directory is not an endorsement.

Multidimensional Assessment of Dyspnea in Asthma (NCT04286906) · Clinical Trials Directory